Literature DB >> 7014931

Treatment of residual, non-infiltrating bladder cancer with bacillus Calmette-Guerin.

A Morales, P Ottenhof, L Emerson.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7014931     DOI： 10.1016/s0022-5347(17)55150-2

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  12 in total

Review 1.  Immunotherapies for bladder cancer: a new hope.

Authors:  Farhad Fakhrejahani; Yusuke Tomita; Agnes Maj-Hes; Jane B Trepel; Maria De Santis; Andrea B Apolo
Journal:  Curr Opin Urol       Date:  2015-11       Impact factor: 2.309

Review 2.  Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review.

Authors:  Elisa Tinazzi; Vincenzo Ficarra; Sara Simeoni; Walter Artibani; Claudio Lunardi
Journal:  Rheumatol Int       Date:  2005-10-12       Impact factor: 2.631

Review 3.  Invasive bladder cancer--possible future treatment considerations.

Authors:  R A Gardiner
Journal:  Urol Res       Date:  1986

4.  The effects of intravesical and intradermal application of a new B.C.G. on the dog bladder.

Authors:  A P vd Meijden; P A Steerenberg; W H de Jong; M J Bogman; W F Feitz; B T Hendriks; F M Debruyne; E J Ruitenberg
Journal:  Urol Res       Date:  1986

5.  Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; P A Steerenberg; W H De Jong; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Nitric oxide is an important mediator for tumoricidal activity in vivo.

Authors:  R Farias-Eisner; M P Sherman; E Aeberhard; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  Bladder instillation of adriamycin in the treatment of bladder cancer.

Authors:  C H Huang; C P Chiang
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 8.  Combination of BCG and interferon intravesical immunotherapy: an update.

Authors:  Kenneth G Nepple; Howard A Aubert; Matthew R Braasch; Michael A O'Donnell
Journal:  World J Urol       Date:  2009-05-29       Impact factor: 4.226

9.  Anti-interleukin-10R1 monoclonal antibody in combination with bacillus Calmette--Guérin is protective against bladder cancer metastasis in a murine orthotopic tumour model and demonstrates systemic specific anti-tumour immunity.

Authors:  M R Newton; E J Askeland; E D Andresen; V A Chehval; X Wang; R W Askeland; M A O'Donnell; Y Luo
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 10.  Intravesical Gene Therapy.

Authors:  Vikram M Narayan; Colin P N Dinney
Journal:  Urol Clin North Am       Date:  2020-02       Impact factor: 2.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.